Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world

Eur Heart J. 2024 Oct 14;45(39):4216-4218. doi: 10.1093/eurheartj/ehae577.
No abstract available

MeSH terms

  • Anticholesteremic Agents / therapeutic use
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / prevention & control
  • Cholesterol, HDL / blood
  • Cholesterol, HDL / metabolism
  • Cholesterol, LDL* / blood
  • Clinical Trials as Topic
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use

Substances

  • Cholesterol, LDL
  • Anticholesteremic Agents
  • Cholesterol, HDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors